MF
ENZ

Magnetar Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Magnetar Financial’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,596
Closed -$121K – 910
2017
Q3 		$121K Buy
+11,596
New +$129K ﹤0.01% 689

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Magnetar Financial's ENZ Position: Q4 2017 in Review

Magnetar Financial sold out of Enzo Biochem, Inc. (ENZ) in Q4 2017, closing a stake of 11,596 shares — an estimated $121K sold.

Magnetar Financial first reported a position in ENZ in Q3 2017 and held it in 1 quarter. The position peaked at $121K in Q3 2017. 115 funds tracked by Wall St. Rank hold ENZ as of Q4 2017.

  • Magnetar Financial reported no remaining Enzo Biochem, Inc. position as of Q4 2017 after selling out during the quarter.
  • Magnetar Financial sold 11,596 Enzo Biochem, Inc. shares in Q4 2017, an estimated $121K.
  • Magnetar Financial first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 1 quarter.
  • Magnetar Financial's Enzo Biochem, Inc. position peaked at $121K in Q3 2017.
  • 115 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2017.

Based on Magnetar Financial's 13F filing for Q4 2017, filed 14 Feb 2018.